Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), put up in measured doses "incl. those for transdermal administration" or in forms or packings for retail sale (excl. containing antibiotics, hormones, alkaloids, provitamins, vitamins, or their derivatives) (EU Only) - European Union
|
Factor
|
Units
|
2007
|
2008
|
2009
|
2010
|
2011
|
2012
|
2013
|
2014
|
2015
|
2016
|
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Import Volume
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 8.5 | 10.6 | 9.1 | 8 |
![]() |
![]() |
![]() |
![]() |
|
Import Value
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2106 | 2689 | 990.7 | 886 |
![]() |
![]() |
![]() |
![]() |
|
Export Volume
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 6796 | 6347 | 1736 | 1732 |
![]() |
![]() |
![]() |
![]() |
|
Export Value
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2652 | 1772 | 188.9 | 205.5 |
![]() |
![]() |
![]() |
![]() |
|
Import Price
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 248.6 | 254.3 | 108.3 | 110.4 |
![]() |
![]() |
![]() |
![]() |
|
Export Price
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 390.3 | 279.1 | 108.8 | 118.6 |
![]() |
![]() |
![]() |
![]() |
|
Net Export Volume
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3279.7 | -5030.9 | -7117.1 | -6004 |
![]() |
![]() |
![]() |
![]() |
|
Net Export Value
|
|
n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 546.3 | -917 | -801.8 | -680.5 |
![]() |
![]() |
![]() |
![]() |
f: forecast
